MMMaheswary Muniandy

Maheswary Muniandy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maheswary Muniandy has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Human whole-blood NAD+ levels do not vary with age or lifestyle interventions

    by Maria M. TręTowicz, Angelique M. L. Scantlebery, Bauke V. Schomakers, Kaan D. Eroğlu, Michel van Weeghel, Vera Spek, Kasper T. Vinten, Luc Legon, Evrim Coskun, Fernando Millan-Domingo, et al.

    Nicotinamide adenine dinucleotide (NAD+) levels in blood and tissues are widely proposed to decline with age, yet evidence in human blood is inconsistent. Using a rigorously validated ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry system that accounts for real-world analytical variability, we quantify NAD+ across seven independent human cohorts. We find that whole-blood NAD+ levels remain remarkably stable with age and across lifestyle interventions, but change in response to nicotinamide riboside supplementation, as expected. Our results challenge the utility of blood NAD+ levels as a biomarker of ageing or lifestyle factors.


  • Open Access

    Opposing patterns in eating behaviors following bariatric surgery versus lifestyle-induced weight loss

    by Laura Vuorela, Bram J. Berntzen, Maheswary Muniandy, Tuure Saarinen, Sanna Meriläinen, Vesa Koivukangas, Laura Suojanen, Per-Henrik Groop, Aila Rissanen, Kirsi Virtanen, et al.

    Objective: This study aimed to investigate 12-month changes in eating behaviors and metabolic outcomes following bariatric surgery or lifestyle-induced weight loss. Methods: This study is a longitudinal secondary analysis comparing data from two independent prospective cohorts: bariatric surgery (n = 19) and lifestyle-induced weight loss intervention (n = 19). Body weight, body composition (Dual-energy X-ray absorptiometer – DEXA), and metabolic parameters (blood samples, Oral Glucose Tolerance test – OGTT) were measured, and eating behaviors were assessed using validated questionnaires (Three-Factor Eating Questionnaire, Dutch Eating Behavior Questionnaire, Binge-Eating Scale) at baseline, at 5–6 months, and at 12 months after the intervention initiation. Results: Bariatric surgery produced greater weight loss (surgery −28.1 ± 8.1 kg vs lifestyle −8.9 ± 7.9 kg; p < 0.001) and larger improvements in metabolic markers than lifestyle-induced weight loss. Despite these differences, eating-behavior trajectories diverged. Bariatric surgery was from baseline to 12 months associated with stable or decreased eating restraint, whereas lifestyle-induced weight loss led to an increase in restraint (cognitive restraint: surgery −0.05 ± 0.7 vs lifestyle +6.4 ± 0.9; p < 0.001; restrained eating: surgery −0.7 ± 0.1 vs lifestyle +0.6 ± 0.2; p < 0.001). Both interventions reduced disinhibited eating, binge eating, and external eating. Hunger-related outcomes also improved in both interventions, but with different signatures: surgery was accompanied by reduced hunger perception and cue-reactivity, whereas lifestyle-induced weight loss was characterized by increased reliance on deliberate cognitive/behavioral control strategies. When changes in eating behaviors were analyzed per 1% body weight lost, the opposing pattern in restraint remained significant, and the lifestyle group showed a larger increase in restraint and a greater relative reduction in susceptibility to hunger compared with surgery. Exploratory item-level patterns supported these profiles, suggesting fewer cue-driven triggers to overeat after surgery and greater use of conscious restraint strategies after lifestyle-induced weight loss. Conclusions: Lifestyle-induced weight loss was associated with increased cognitive restraint, whereas bariatric surgery resulted in stable or decreased restraint. Both interventions decreased hunger sensations, likely through adaptive learning in the lifestyle group and physiological changes after surgery.

  • Open Access

    The effect of obesity and aging on NAD+/Sirtuin metabolism transcription and DNA methylation in subcutaneous adipose tissue of monozygotic twin pairs discordant for BMI

    by Helena A. K. Lapatto, Birgitta W. van der Kolk, Maheswary Muniandy, Sini Heinonen, Aino Heikkinen, Marcus Alvarez, Seung Hyuk T. Lee, Riikka Jokinen, Jesper Lundbom, Juho Kuula, et al.

    Introduction The expression and/or activity of sirtuins (SIRTs), nicotinamide adenine dinucleotide (NAD+)-dependent enzymes that regulate cellular energy metabolism, is decreased in obesity and in aging in animal models. However, the impact of obesity compared to aging on NAD+/SIRT expression in human white adipose tissue (AT) remains unexplored. Here, we unravel the effects of obesity and aging on the expression of NAD+/SIRT pathway and their associated genes in subcutaneous AT of identical twin pairs discordant for weight, in two age groups. Methods We examined 49 monozygotic twin pairs discordant for BMI (within-pair difference in BMI ≥ 2.5 kg/m2, with mean BMIs 25.6 kg/m2 (leaner) and 30.8 kg/m2 (heavier), aged 22–38 and 56–69 years. Detailed phenotyping included body composition, insulin resistance (oral glucose tolerance test) and plasma lipids and inflammation markers. RNA sequencing and DNA methylation analyses in AT identified differentially expressed and methylated NAD+/SIRT pathway genes in obesity and aging, with linear mixed models linking gene expression to metabolic features. Results SIRT5 and NAD+ biosynthetic genes were downregulated in AT in both obesity and aging. Obesity was characterized by downregulation of AT NAD+/SIRT genes, and NAD+/SIRT regulated mitochondrial oxidative metabolism genes, and upregulation of stress markers. Aging showed a downregulation of AT PARPs, except upregulation for PARP1, a main consumer of NAD+. Mitochondrial metabolism and glycolysis genes were linked to corresponding DNA methylation. Downregulation of NAD+/SIRT genes correlated with increased adiposity, insulin resistance, inflammation, and dyslipidemia. Conclusion Impaired NAD+/SIRT metabolism in AT may play a key role in obesity- and aging-related diseases. Both conditions are characterized by downregulation of NAD+/SIRT pathway genes, correlating with increased adiposity, insulin resistance, inflammation, and dyslipidemia. Obesity uniquely disrupts expression of NAD+/SIRT regulated mitochondrial genes, while aging is characterized by altered PARP expression, particularly increased PARP1, likely exacerbating metabolic dysfunction in AT.


  • Open Access

    Sex‐Specific Subcutaneous Adipose Tissue Transcriptome in Obesity: Insights From Monozygotic Twin Pairs Discordant for BMI

    by Hanna Haltia, Maheswary Muniandy, Sini Heinonen, Sina Saari, Marcus Alvarez, Antti Hakkarainen, Jesper Lundbom, Juho Kuula, Per‐Henrik Groop, Jaakko Kaprio, et al.

    Objective: We investigated the impact of sex on the subcutaneous adipose tissue (AT) transcriptome and its obesity‐related adaptations. Methods: We studied rare BMI‐discordant monozygotic twin pairs (ΔBMI > 2.5 kg/m 2 ; 21 female, 16 male pairs) to assess how sex affects AT and whole‐body metabolism. AT RNA sequencing was analyzed using linear mixed modeling and pathway enrichment for: (1) sex differences in individual twins, adjusted for BMI, (2) sex‐stratified effects of acquired obesity (ΔBMI between co‐twins separately in females and males), (3) sex‐specific effects of obesity (differences in the ΔBMI effect between sexes). Results: (1) AT transcriptional profiles differed between sexes, associating with insulin sensitivity. (2) Sex‐stratified obesity effects within pairs were stronger in females, with upregulated inflammation and downregulated mitochondrial oxidative phosphorylation; males showed increased inflammation and decreased histone modification. (3) The response to obesity was sex‐specific: lower expression of genes in unsaturated fatty acid metabolism in obesity was seen in females only. Sex‐specific obesity AT gene expression was associated with metabolic health, with a negative association between unsaturated fatty acid metabolism and insulin sensitivity in males only. Conclusions: Biological sex influences the AT transcriptome and its response to obesity, highlighting distinct molecular mechanisms that may contribute to sex‐specific metabolic health.


  • Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study

    by Helena A. K. Lapatto, Minna Kuusela, Aino Heikkinen, Maheswary Muniandy, Birgitta W. van der Kolk, Swetha Gopalakrishnan, Noora Pöllänen, Martin Sandvik, Mark S. Schmidt, Sini Heinonen, et al.

    Nicotinamide adenine dinucleotide (NAD + ) precursor nicotinamide riboside (NR) has emerged as a promising compound to improve obesity-associated mitochondrial dysfunction and metabolic syndrome in mice. However, most short-term clinical trials conducted so far have not reported positive outcomes. Therefore, we aimed to determine whether long-term NR supplementation boosts mitochondrial biogenesis and metabolic health in humans. Twenty body mass index (BMI)–discordant monozygotic twin pairs were supplemented with an escalating dose of NR (250 to 1000 mg/day) for 5 months. NR improved systemic NAD + metabolism, muscle mitochondrial number, myoblast differentiation, and gut microbiota composition in both cotwins. NR also showed a capacity to modulate epigenetic control of gene expression in muscle and adipose tissue in both cotwins. However, NR did not ameliorate adiposity or metabolic health. Overall, our results suggest that NR acts as a potent modifier of NAD + metabolism, muscle mitochondrial biogenesis and stem cell function, gut microbiota, and DNA methylation in humans irrespective of BMI.


  • Author Correction: The mitochondrial protein Opa1 promotes adipocyte browning that is dependent on urea cycle metabolites

    by Camilla Bean, Matteo Audano, Tatiana Varanita, Francesca Favaretto, Marta Medaglia, Marco Gerdol, Lena Pernas, Fabio Stasi, Marta Giacomello, Stèphanie Herkenne, et al.


  • The mitochondrial protein Opa1 promotes adipocyte browning that is dependent on urea cycle metabolites

    by Camilla Bean, Matteo Audano, Tatiana Varanita, Francesca Favaretto, Marta Medaglia, Marco Gerdol, Lena Pernas, Fabio Stasi, Marta Giacomello, Stèphanie Herkenne, et al.

    White to brown/beige adipocytes conversion is a possible therapeutic strategy to tackle the current obesity epidemics. While mitochondria are key for energy dissipation in brown fat, it is unknown if they can drive adipocyte browning. Here, we show that the mitochondrial cristae biogenesis protein optic atrophy 1 (Opa1) facilitates cell-autonomous adipocyte browning. In two cohorts of patients with obesity, including weight discordant monozygotic twin pairs, adipose tissue OPA1 levels are reduced. In the mouse, Opa1 overexpression favours white adipose tissue expandability as well as browning, ultimately improving glucose tolerance and insulin sensitivity. Transcriptomics and metabolomics analyses identify the Jumanji family chromatin remodelling protein Kdm3a and urea cycle metabolites, including fumarate, as effectors of Opa1-dependent browning. Mechanistically, the higher cyclic adenosine monophosphate (cAMP) levels in Opa1 pre-adipocytes activate cAMP-responsive element binding protein (CREB), which transcribes urea cycle enzymes. Flux analyses in pre-adipocytes indicate that Opa1-dependent fumarate accumulation depends on the urea cycle. Conversely, adipocyte-specific Opa1 deletion curtails urea cycle and beige differentiation of pre-adipocytes, and is rescued by fumarate supplementation. Thus, the urea cycle links the mitochondrial dynamics protein Opa1 to white adipocyte browning.


  • Open Access

    Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity

    by Sanna Kaye, A. Inkeri Lokki, Anna Hanttu, Eija Nissilä, Sini Heinonen, Antti Hakkarainen, Jesper Lundbom, Nina Lundbom, Lilli Saarinen, Olli Tynninen, et al.

    Inflammation is an important mediator of obesity-related complications such as the metabolic syndrome but its causes and mechanisms are unknown. As the complement system is a key mediator of inflammation, we studied whether it is activated in acquired obesity in subcutaneous adipose tissue and isolated adipocytes. We used a special study design of genetically matched controls of lean and heavy groups, rare monozygotic twin pairs discordant for BMI (n=26, within-pair difference (in body mass index, kg/m2with as much as 18 kg mean weight. Additionally, 14 BMI-concordant (kg/m2) served as a reference group. The detailed measurements included body composition (DEXA), fat distribution (MRI), glucose, insulin, adipokines, C3a and SC5b-9 levels and the expression of complement and insulin signaling pathway-related genes in adipose tissue and adipocytes. In both adipose tissue and isolated adipocytes, the classical and alternative pathway genes were upregulated, and the terminal pathway genes downregulated in the heavier co-twins of the BMI-discordant pairs. The up-regulated genes included C1q, C1s, C2, ficolin-1, factor H, receptors for C3a and C5a (C5aR1) and the iC3b receptor (CR3). While the terminal pathway components C5 and C6 were downregulated, its inhibitor clusterin was upregulated. Complement gene up-regulation in adipose tissue and adipocytes correlated positively with adiposity and hyperinsulinemia, and negatively with the expression of insulin signaling related genes. Plasma C3a, but not SC5b-9, levels were elevated in the heavier co-twins. There were no differences between the co-twins in BMI-concordant pairs. Obesity is associated with increased expression of the early, but not late, complement pathway components and of key receptors. The twins with acquired obesity have therefore an inflated inflammatory activity in the adipose tissue. The results suggest that complement is likely involved in orchestrating clearance of apoptotic debris and inflammation in the adipose tissue.


  • Open Access

    Mitochondria-related transcriptional signature is downregulated in adipocytes in obesity: a study of young healthy MZ twins

    by Sini Heinonen, Maheswary Muniandy, Jana Buzkova, Adil Mardinoglu, Amaia Rodríguez, Gema Frühbeck, Antti Hakkarainen, Jesper Lundbom, Nina Lundbom, Jaakko Kaprio, et al.

    Aims/hypothesis Low mitochondrial activity in adipose tissue is suggested to be an underlying factor in obesity and its metabolic complications. We aimed to find out whether mitochondrial measures are downregulated in obesity also in isolated adipocytes. Methods We studied young adult monozygotic (MZ) twin pairs discordant (n = 14, intrapair difference ΔBMI ≥ 3 kg/m2) and concordant (n = 5, ΔBMI < 3 kg/m2) for BMI, identified from ten birth cohorts of 22- to 36-year-old Finnish twins. Abdominal body fat distribution (MRI), liver fat content (magnetic resonance spectroscopy), insulin sensitivity (OGTT), high-sensitivity C-reactive protein, serum lipids and adipokines were measured. Subcutaneous abdominal adipose tissue biopsies were obtained to analyse the transcriptomics patterns of the isolated adipocytes as well as of the whole adipose tissue. Mitochondrial DNA transcript levels in adipocytes were measured by quantitative real-time PCR. Western blots of oxidative phosphorylation (OXPHOS) protein levels in adipocytes were performed in obese and lean unrelated individuals. Results The heavier (BMI 29.9 ± 1.0 kg/m2) co-twins of the discordant twin pairs had more subcutaneous, intra-abdominal and liver fat and were more insulin resistant (p < 0.01 for all measures) than the lighter (24.1 ± 0.9 kg/m2) co-twins. Altogether, 2538 genes in adipocytes and 2135 in adipose tissue were significantly differentially expressed (nominal p < 0.05) between the co-twins. Pathway analysis of these transcripts in both isolated adipocytes and adipose tissue revealed that the heavier co-twins displayed reduced expression of genes relating to mitochondrial pathways, a result that was replicated when analysing the pathways behind the most consistently downregulated genes in the heavier co-twins (in at least 12 out of 14 pairs). Consistently upregulated genes in adipocytes were related to inflammation. We confirmed that mitochondrial DNA transcript levels (12S RNA, 16S RNA, COX1, ND5, CYTB), expression of mitochondrial ribosomal protein transcripts and a major mitochondrial regulator PGC-1α (also known as PPARGC1A) were reduced in the heavier co-twins’ adipocytes (p < 0.05). OXPHOS protein levels of complexes I and III in adipocytes were lower in obese than in lean individuals. Conclusions/interpretation Subcutaneous abdominal adipocytes in obesity show global expressional downregulation of oxidative pathways, mitochondrial transcripts and OXPHOS protein levels and upregulation of inflammatory pathways. Data availability The datasets analysed and generated during the current study are available in the figshare repository, https://dx.doi.org/10.6084/m9.figshare.3806286.v1


  • Open Access

    Obesity Is Associated With Low NAD+/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins

    by Sakari Jukarainen, Sini Heinonen, Joel T. Rämö, Rita Rinnankoski-Tuikka, Elisabeth Rappou, Mark Tummers, Maheswary Muniandy, Antti Hakkarainen, Jesper Lundbom, Nina Lundbom, et al.

    Context: Sirtuins (SIRTs) regulate cellular metabolism and mitochondrial function according to the energy state of the cell reflected by NAD+ levels. Objective: Our aim was to determine whether expressions of SIRTs and NAD+ biosynthesis genes are affected by acquired obesity and how possible alterations are connected with metabolic dysfunction while controlling for genetic and familial factors. Design and Participants: We studied a cross-sectional sample of 40 healthy pairs of monozygotic twins, including 26 pairs who were discordant for body mass index (within-pair difference > 3 kg/m2), from the FinnTwin12 and FinnTwin16 cohorts. Main Outcome Measures: Subcutaneous adipose tissue (SAT) transcriptomics was analyzed by using Affymetrix U133 Plus 2.0 chips, total SAT (poly-ADP) ribose polymerase (PARP) activity by an ELISA kit, body composition by dual-energy x-ray absorptiometry and magnetic resonance imaging/spectroscopy, and insulin sensitivity by an oral glucose tolerance test. Results: SIRT1, SIRT3, SIRT5, NAMPT, NMNAT2, NMNAT3, and NRK1 expressions were significantly down-regulated and the activity of main cellular NAD+ consumers, PARPs, trended to be higher in the SAT of heavier co-twins of body mass index–discordant pairs. Controlling for twin-shared factors, SIRT1, SIRT3, NAMPT, NMNAT3, and NRK1 were significantly negatively correlated with adiposity, SIRT1, SIRT5, NMNAT2, NMNAT3, and NRK1 were negatively correlated with inflammation, and SIRT1 and SIRT5 were positively correlated with insulin sensitivity. Expressions of genes involved in mitochondrial unfolded protein response were also significantly down-regulated in the heavier co-twins. Conclusions: Our data highlight a strong relationship of reduced NAD+/SIRT pathway expression with acquired obesity, inflammation, insulin resistance, and impaired mitochondrial protein homeostasis in SAT.